California settles opioid complaint with same company selling the state overdose meds

California Attorney General Rob Bonta has announced a $273 million multistate settlement with New Jersey-based Amneal Pharmaceutical for the drug manufacturer’s alleged failure to report suspicious opioid orders, and as a consequence contributing to the opioid epidemic. 

If the name “Amneal Pharmaceuticals” rings a bell, it’s because just days earlier Gov. Gavin Newsom and state health officials announced a deal with this same company to procure naloxone, the overdose reversal medication, at a cheaper price than currently available. That agreement locks that state in as a long-term customer to the company.